Felix Betzler
Psychiatrist and psychotherapist
Data updated
Research Footprint
Felix Betzler appears in 5 tracked papers (2020–2026), most studied alongside Psilocybin and Placebo, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Substance Use Disorders (SUD).
Most-cited paper: Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance (184 citations).
Frequent co-authors: Gerhard Gründer, Lea Mertens and Henrik Jungaberle.
Background & Research
Felix Betzler is a physician specializing in psychiatry and psychotherapy at Charité – Universitätsmedizin Berlin. He also leads the Charité research group “Recreational Drugs” and a specialty clinic for patients with substance use-related disorders. His training includes medicine and psychiatry at Charité, philosophy at Humboldt University Berlin, and a doctoral degree from Harvard Medical School; his research spans substance use, harm reduction, and psychedelic therapy.
Key Impact
Felix Betzler is a psychiatrist and psychotherapy researcher whose work appears on multiple psychedelic and substance-use papers, including the EPIsoDE psilocybin trial program.
Collaboration Network
8 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Felix Betzler is associated with.